Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joncker, N. T.
Right arrow Articles by Lantz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joncker, N. T.
Right arrow Articles by Lantz, O.
[Cancer Research 66, 5443-5451, May 15, 2006]
© 2006 American Association for Cancer Research


Immunology

Intratumor CD4 T-Cell Accumulation Requires Stronger Priming than for Expansion and Lymphokine Secretion

Nathalie T. Joncker, Julie Helft, Alexandra Jacquet, Virginie Premel and Olivier Lantz

Laboratoire d'Immunologie pré-clinique, Institut National de la Sante et de la Recherche Medicale U653, Institut Curie, Paris, France

Requests for reprints: Olivier Lantz, Laboratoire d'Immunologie pré-clinique, Institut National de la Sante et de la Recherche Medicale U653, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Phone: 33-144-324-218; Fax: 33-144-324-444; E-mail: Olivier.lantz{at}curie.net.

T cells need to migrate to and accumulate inside tumors before mediating rejection of the tumor. The number of specific T cells inside tumors may depend on the efficiency of priming in the draining lymph node (DLN), intratumor deletion, suppressive phenomena, or both. We used monoclonal anti-male antigen CD4 (Marilyn) T cells and tumor cell lines expressing or not the corresponding antigen (Dby) to analyze CD4 T-cell accumulation in tumors. Priming by MHC II+ or MHC II male splenocytes or Dby+ tumor cells induced similar Marilyn T-cell expansion in the DLN and recirculation in other lymph nodes and capacity to produce IFN-{gamma}. However, intratumor accumulation was different for each priming condition. In mice with Dby tumors, MHC II+ male splenocyte priming induced greater, although not statistically significant, Marilyn T-cell accumulation in the tumors than MHC II male splenocyte priming. In mice with Dby+ tumors, priming in the tumor DLN induced less Marilyn T-cell intratumor accumulation than priming by MHC II+ male splenocytes. We saw comparable differences for Marilyn T-cell accumulation in gut lamina propria, suggesting that priming affects effector T-cell accumulation in inflamed tissues. Mature dendritic cells were loaded with graded doses of Dby peptide to control for antigen-presenting cell characteristics during priming. We observed similar proliferation, with higher concentrations inducing higher intratumor accumulation. Thus, intratumor accumulation requires stronger stimulation than for proliferation or the capacity to secrete lymphokines. In this system, priming intensity alone can explain the number of intratumor T cells without having to call for intratumor deletion or suppression phenomena. (Cancer Res 2006; 66(10): 5443-51)




This article has been cited by other articles:


Home page
J. Immunol.Home page
M.-G. de Goer de Herve, A. Cariou, F. Simonetta, and Y. Taoufik
Heterospecific CD4 Help to Rescue CD8 T Cell Killers
J. Immunol., November 1, 2008; 181(9): 5974 - 5980.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Helft, A. Jacquet, N. T. Joncker, I. Grandjean, G. Dorothee, A. Kissenpfennig, B. Malissen, P. Matzinger, and O. Lantz
Antigen-specific T-T interactions regulate CD4 T-cell expansion
Blood, August 15, 2008; 112(4): 1249 - 1258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.